For Immediate Release
Chicago, IL – June 14, 2017 - Stocks in this week’s article include Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN – Free Report ), Raymond James Financial, Inc. (NYSE: RJF – Free Report ), Dollar General Corporation (NYSE:DG) (NYSE: DG – Free Report ), Xcel Energy Inc (NYSE:XEL). (NYSE: XEL – Free Report ) and Morgan Stanley (NYSE:MS) (NYSE: MS – Free Report ).
Screen of the Week of Zacks Investment Research:
5 Stocks with Solid Sales Growth Catching Eyeballs
Investors often fail to watch for sales growth while selecting stocks, as a company’s stock price is usually sensitive to its earnings momentum. Nonetheless, earnings are not the be-all and end-all in the sense that books can be easily manipulated. That’s why sales should always be taken into consideration.
Sales growth is actually an important indicator of a company's health and ability to sustain its business. It offers investors an insight into product demand and pricing power. The main advantage is that the sales figure is generally not manipulated and is less volatile than earnings.
Without some revenue growth, bottom-line improvement may not be sustainable in the longer term. While a company can show earnings strength by reducing expenses, a sustainable bottom-line recovery usually requires sales growth.
Focusing exclusively on sales growth is not enough though. A healthy sales growth rate is certainly a positive indicator for picking good stocks, but it does not ensure profits. So, taking into consideration a company’s cash position along with its sales number can prove to be a more dependable strategy.
Substantial cash on hand and a steady cash flow give a company more flexibility with respect to business decisions and potential investments. Cash also enables a company to endure market downturns. Most importantly, a sufficient cash position indicates that revenues are being channelized in the right direction.
Picking the Winning Stocks
In order to shortlist stocks that have witnessed impressive sales growth along with a high cash balance, we have selected 5-Year Historical Sales Growth (%) greater than X-Industry and Cash Flow greater than $500 million as our main screening parameters.
But sales growth and cash strength are not the absolute criteria for selecting stocks. So, we added certain other factors to arrive at a winning strategy.
Price-to-Sales (P/S) Ratio less than X-Industry: This metric determines the value placed on each dollar of a company’s revenues. The lower the ratio, the better it is for picking a stock since the investor is paying less for each unit of sales.
% Change F1 Sales Estimate Revisions (4 Weeks) greater than X-Industry: Better-than-industry estimate revision has often been seen to trigger an increase in the stock price.
Operating Margin (Average Last 5 years) greater than 5%: Operating margin measures how much every dollar of a company's sales translates into profits. A high ratio indicates that the company has good cost control and sales are increasing faster than costs, an optimal situation for the company.
Return on Equity (ROE) greater than 5%: This metric will ensure that sales growth is being translated into profits and the company is not hoarding cash. A high ROE means the company is spending wisely and is in all likelihood profitable.
Zacks Rank less than or equal to 2: Zacks Rank #1 (Strong Buy) or 2 (Buy) stocks are known to outperform irrespective of the market environment.
Here are five of the 14 stocks that qualified the screening:
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report ), based in Tarrytown, NY, is a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. It has long-term expected earnings per share (EPS) growth rate of 21.1%. The company carries a Zacks Rank #2.
Raymond James Financial, Inc. (NYSE:RJF – Free Report ) is engaged in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products. This St. Petersburg, FL-based company currently has long-term expected EPS growth rate of 17% and sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here .
Dollar General Corporation (NYSE:DG – Free Report ), based in Goodlettsville, TN, is a discount retailer, providing various merchandise products. The company has a long-term expected EPS growth rate of 10.6% and carries a Zacks Rank #2.
Xcel Energy Inc. (NYSE:XEL – Free Report ) is engaged mainly in the generation, purchase, transmission, distribution and sale of electricity. This Minneapolis, MN-based company has a long-term expected EPS growth rate of 5.4% and a Zacks Rank #2.
Headquartered in New York, Morgan Stanley (NYSE: MS – Free Report ) provides various financial products and services to corporations, governments, financial institutions, and individuals. The company currently has a long-term expected EPS growth rate of 13.2% and a Zacks Rank #2.
Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today .
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance .
Zacks Restaurant Recommendations: In addition to dining at these special places, you can feast on their stock shares. A Zacks Special Report spotlights 5 recent IPOs to watch plus 2 stocks that offer immediate promise in a booming sector. Download it free »
Sign up now for your free trial today and start picking better stocks immediately. And with the backtesting feature, you can test your ideas to see how you can improve your trading in both up markets and down markets. Don’t wait for the market to get better before you decide to do better. Start learning how to be a better trader today: https://at.zacks.com/?id=111
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Each week, Zacks Profit from the Pros free email newsletter shares a new screening strategy. Learn more about it here https://at.zacks.com/?id=112
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros .
Get the full Report on REGN - FREE
Get the full Report on RJF - FREE
Get the full Report on DG - FREE
Get the full Report on XEL - FREE
Get the full Report on MS - FREE
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook (NASDAQ:FB): https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/performance
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer .
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Regeneron Pharmaceuticals, Inc. (REGN): Free Stock Analysis Report
Raymond James Financial, Inc. (RJF): Free Stock Analysis Report
Dollar General Corporation (DG): Free Stock Analysis Report
Xcel Energy Inc. (XEL): Free Stock Analysis Report
Morgan Stanley (MS): Free Stock Analysis Report
Original post
Zacks Investment Research